Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
May 29, 2024 3:35 PM 4 min read

Ulta Beauty Q1 Earnings Preview: Positive Foot Traffic Data May Offset Concerns Over Same-Store Sales

by Chris Katje Benzinga Staff Writer
Follow

Beauty retailer Ulta Beauty, Inc. (NASDAQ:ULTA) will report first-quarter financial results after market close Thursday, May 30, 2024.

Here are the earnings estimates, what analysts are saying and key items to watch.

Earnings Estimates: Analysts expect Ulta to report first-quarter revenue of $2.72 billion, according to data from Benzinga Pro.

The company reported revenue of $3.23 billion in last year's first quarter. Ulta has beaten analysts' revenue estimates in 10 straight quarters.

Analysts expect the company to report first-quarter earnings per share of $6.23 compared to $6.88 in last year's first quarter. The company has beaten analysts' earnings per share estimates in 10 straight quarters.

The company is guiding for fiscal 2024 revenue to be in a range of $11.7 billion to $11.8 billion and earnings per share to be in a range of $26.20 to $27.00.

"While we are mindful the near-term macro environment remains dynamic, we are optimistic about the resiliency of the beauty category, energized by the growth opportunities ahead of us, and confident in our ability to deliver for our guests and our shareholders," Ulta CEO David Kimbell said after Q4 results.

What Analysts Are Saying: Nielsen data could point to a flat quarter for Ulta Beauty, JPMorgan analyst Christopher Horvers said in a recent note.

The data showed total beauty products in the food, drug and mass channels were up 1.2% for the four weeks ending May 18 and up 1.7% for the four weeks prior to that.

"That said, Ulta's same-store sales have a 63% correlation with NielsenIQ cosmetics trends and nearly 50% with beauty," Horvers said.

The analyst has a Buy rating on Ulta and lowered the price target from $600 to $530.

"Looking at the full period, the data continue to imply a flattish comp for 1Q24, consistent with expectations that we previewed with moderation since the company commentary at our conference in early April.”

The analyst said the one-year and five-year trends are largely accelerated, led by the fragrance category.

Categories like cosmetics, facial skin care and hand/body/lotion all saw lower growth than in the previous month in the latest Nielsen data, with the fragrance category outperforming at +17.5% compared to +12.8% in the prior month.

Other analysts have been lowering their price targets on Ulta stock ahead of earnings. Here are recent analyst ratings on Ulta Beauty and their price targets.

Related Link: Ulta Beauty Faces Headwinds From Slowing Trends, Notes Analyst

Key Items to Watch: In April, Ulta presented at a JPMorgan conference and said that it wouldn't be able to generate 15%+ margins on more moderated comp sales of 3% to 4%. The company also said its first-quarter same store sales would come in the lower end of low single-digit growth guidance.

A recent report on foot traffic from Placer.ai shows that Ulta is seeing strong year-over-year visit growth, which is outpacing other retailers in the Beauty and Wellness category.

The report said visits between January and April 2024 for Ulta were higher than the previous year and ahead of the sector.

Placer.ai showed Ulta visits up 3.1% in April, up 12.1% in March and up 9.0% in February on a year-over-year basis. The overall beauty and wellness segment had year-over-year growth of 0.5% in April, 8.2% in March and 6.7% in February, according to the report.

"Ulta continues to experience visit growth, highlighting Beauty's enduring appeal," the report said.

Investors and analysts will be closely watching the report to see if the strong foot traffic can help the company again beat revenue and earnings per share estimates.

ULTA Price Action: Ulta shares trade at $379.97 versus a 52-week trading range of $368.02 to $574.76. Ulta stock is down 7.9% over the last year and down 22.5% year-to-date in 2024.

Read Next: Ulta’s Strategic Moves And Market Share Poise Spark Optimism, Analysts Elevate Forecasts Post-Q4 Triumph

The average American couple has saved this much money for retirement — How do you compare?

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorPrice TargetPreviewsReiterationAnalyst RatingsTrading IdeasChristopher HorversExpert IdeasJPMorganretailRetail StocksStories That Matter
ULTA Logo
ULTAUlta Beauty Inc
$688.183.15%
Overview
  • Canaccord Genuity: Buy rating, lowered price target from $575 to $522
  • Baird: Outperform rating, lowered price target from $625 to $525
  • Bank of America: Neutral rating, lowered price target from $575 to $425
  • Citigroup: Neutral rating, lowered price target from $485 to $400
  • Jefferies: Hold rating, lowered price target from $438 to $412
  • Telsey: Outperform rating, lowered price target from $600 to $500
  • Piper Sandler: Overweight rating, lowered price target from $595 to $505
  • Goldman Sachs: Neutral rating, lowered price target from $605 to $476
ULTA Logo
ULTAUlta Beauty Inc
$688.183.15%
Overview
Comments
Loading...